Graham Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,237
| Closed | -$552K | – | 1265 |
|
|
2025
Q1 | $552K | Sell |
6,237
-19,023
| -75% | -$1.68M | 0.01% | 734 |
|
|
2024
Q4 | $2.2M | Buy |
25,260
+8,283
| +49% | +$722K | 0.03% | 244 |
|
|
2024
Q3 | $1.57M | Buy |
16,977
+14,021
| +474% | +$1.3M | 0.03% | 319 |
|
|
2024
Q2 | $319K | Sell |
2,956
-30
| -1% | -$3.23K | 0.01% | 687 |
|
|
2024
Q1 | $283K | Sell |
2,986
-2,167
| -42% | -$206K | 0.01% | 783 |
|
|
2023
Q4 | $475K | Sell |
5,153
-2,746
| -35% | -$253K | 0.01% | 579 |
|
|
2023
Q3 | $397K | Buy |
+7,899
| New | +$397K | 0.01% | 615 |
|
|
2022
Q4 | – | Sell |
-17,195
| Closed | -$1.13M | – | 1052 |
|
|
2022
Q3 | $1.13M | Sell |
17,195
-42,878
| -71% | -$2.82M | 0.04% | 421 |
|
|
2022
Q2 | $3.03M | Buy |
60,073
+56,146
| +1,430% | +$2.84M | 0.12% | 106 |
|
|
2022
Q1 | $250K | Buy |
+3,927
| New | +$250K | 0.01% | 775 |
|